...
首页> 外文期刊>Cell death & disease. >Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1
【24h】

Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels: involvement of NOX2 and SOD1

机译:通过调节NRF 2稳定介导的ROS水平来抑制丁酸钠抑制高胆固醇诱导的神经元淀粉样蛋白:NOX2和SOD1的累积

获取原文
           

摘要

The gut-brain axis is currently being studied as a therapeutic strategy for neurological diseases, especially Alzheimer's disease (AD). Obesity results in the gut microbiota dysbiosis, which includes butyrate-producing bacteria are reduced. Although sodium butyrate (NaB) has emerged as the potential therapeutic substance in AD, there is a lack of detailed results into what signaling pathways affect amyloidogenesis in AD induced by obesity. Thus, we investigated the regulatory role of NaB on amyloidogenesis in neuronal cells under high cholesterol. In our results, we verified that increased amyloid β peptide (Aβ) accumulation in the brain of obese mice and a reduction in butyrate-producing bacteria due to the gut microbiota dysbiosis induced by obesity. We showed that NaB decreased the expression levels of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and Aβ accumulation induced by high cholesterol in SK-N-MC cells. We demonstrated that NaB was absorbed in cells through sodium-coupled monocarboxylate transporter 1 (SMCT1) and then inhibited high cholesterol-induced Aβ accumulation. Subsequently, we also observed that reactive oxygen species (ROS) were overproduced because of increased NADPH oxidase 2 (NOX2) expression under high cholesterol. Meanwhile, NaB decreased NOX2 levels through a reduction of NF-κB activity, which ultimately inhibited Aβ accumulation caused by high cholesterol. We demonstrated that NaB increased the expression levels of p21 under high cholesterol, contributing to p21/NRF2 (Nuclear factor erythroid 2-related factor 2) colocalization, which leads to NRF2 stabilization. NRF2 stabilization causes NF-κB inactivation, followed by NOX2 suppression and superoxide dismutase 1 (SOD1) upregulation. Thus, NaB with SOD1 silencing under high cholesterol did not eliminate excessive ROS, and eventually resulted in Aβ accumulation. In conclusion, we demonstrated that NaB prevents excessive ROS through NOX2 suppression and SOD1 upregulation by p21/NRF2 pathway, which is critical for inhibiting BACE1-dependent amyloidogenesis in neuronal cells exposed to high cholesterol environment.
机译:目前正在研究肠脑轴作为神经疾病的治疗策略,特别是阿尔茨海默病(AD)。肥胖导致肠道微生物瘤功能分泌,包括产生丁酸的细菌。虽然丁酸钠(NAB)被出现为AD中的潜在治疗物质,但缺乏详细的结果进入了通过肥胖诱导的AD中的淀粉样胺发生的信号通路。因此,我们研究了Nab对高胆固醇下神经元细胞中淀粉样细胞的调节作用。在我们的结果中,我们验证了由于肥胖诱导的肠道微生物症脱虫病导致的肥胖小鼠脑中增加的淀粉样蛋白β肽(Aβ)积累和产生的丁酸盐的细菌。我们表明,NAb降低了通过高胆固醇在SK-N-MC细胞中诱导的β-位点淀粉样蛋白前体蛋白切割酶1(BACE1)的表达水平和Aβ积累。我们证明NAB通过钠偶联的单羧酸盐转运蛋白1(SMCT1)在细胞中被吸收,然后抑制高胆固醇诱导的Aβ积累。随后,我们还观察到,由于在高胆固醇下的NADPH氧化酶2(NOX2)表达增加,过度抑制了活性氧物质(ROS)。同时,NAB通过降低NF-κB活性降低NOx2水平,最终抑制了高胆固醇引起的Aβ积累。我们证明,NAB在高胆固醇下增加了P21的表达水平,有助于P21 / NRF2(核因子红细胞2相关因子2)分层化,这导致NRF2稳定化。 NRF2稳定导致NF-κB灭活,然后是NOx2抑制和超氧化物歧化酶1(SOD1)上调。因此,在高胆固醇下具有SOD1沉默的NAB并未消除过量的ROS,最终导致Aβ积累。总之,我们证明NAB通过P21 / NRF2途径通过NOx2抑制和SOD1上调的过量RO,这对于抑制暴露于高胆固醇环境的神经元细胞中的Bace1依赖性淀粉样淀粉是至关重要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号